Montreal, Canada

Javier Mazzaferri

This inventor holds 1 USPTO granted patent. Top assignee: Ecole Polytechnique. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Javier Mazzaferri

Introduction

Javier Mazzaferri is a notable inventor based in Montreal, Canada. He has made significant strides in the field of biomolecular delivery systems, particularly concerning the eye. His work focuses on innovative methods that enhance the delivery of therapeutic agents to target cells.

Latest Patents

Mazzaferri holds a patent for a groundbreaking invention titled "Method and system for delivering exogenous biomolecules into the eye and method for forming pores into target cells of an eye." This patent describes a method that involves injecting a mixture of exogenous biomolecules and plasmonic structures into a specific region of the eye. The plasmonic structures, which have a plasmonic resonance wavelength, are designed to adjoin the membranes of target cells. By irradiating the region with a laser beam, the plasmonic structures create pores in the membranes, allowing the biomolecules to enter the target cells effectively.

Career Highlights

Mazzaferri's career is marked by his dedication to advancing medical technology. His innovative approach to biomolecular delivery has the potential to revolutionize treatments for various eye conditions. His work is a testament to the importance of research and development in the medical field.

Collaborations

Throughout his career, Mazzaferri has collaborated with esteemed colleagues such as Michel Meunier and Ariel Wilson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Javier Mazzaferri's contributions to the field of biomolecular delivery systems are noteworthy. His innovative patent demonstrates the potential for significant advancements in medical treatments for the eye. His work continues to inspire future research and development in this critical area of healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…